{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:05:19Z","timestamp":1774976719492,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-023-01528-y","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T13:37:28Z","timestamp":1675258648000},"page":"515-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Maria Vittoria","family":"Veneroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Maria","family":"Festa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Spriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Mercante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0738-8223","authenticated-orcid":false,"given":"Armando","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"issue":"1","key":"1528_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE De Visser","year":"2006","unstructured":"De Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24\u201337. https:\/\/doi.org\/10.1038\/nrc1782","journal-title":"Nat Rev Cancer"},{"issue":"7203","key":"1528_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"issue":"9","key":"1528_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS (2020) The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol 30(9):695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003","journal-title":"Trends Cell Biol"},{"issue":"5","key":"1528_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s0952-7915(98)80228-8","volume":"10","author":"DM Pardoll","year":"1998","unstructured":"Pardoll DM, Topalian SL (1998) The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol 10(5):588\u2013594. https:\/\/doi.org\/10.1016\/s0952-7915(98)80228-8","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"1528_CR5","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1084\/jem.186.12.2057","volume":"186","author":"C Kurts","year":"1997","unstructured":"Kurts C, Carbone FR, Barnden M et al (1997) CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 186(12):2057\u20132062. https:\/\/doi.org\/10.1084\/jem.186.12.2057","journal-title":"J Exp Med"},{"key":"1528_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141122","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"1528_CR7","first-page":"745","volume":"8","author":"TY Shibuya","year":"2002","unstructured":"Shibuya TY, Nugyen N, McLaren CE et al (2002) Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 8(3):745\u2013751","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1528_CR8","first-page":"24","volume":"5","author":"S Russell","year":"2013","unstructured":"Russell S, Angell T, Lechner M et al (2013) Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol 5(3):24","journal-title":"Head Neck Oncol"},{"issue":"6","key":"1528_CR9","doi-asserted-by":"publisher","first-page":"e38711","DOI":"10.1371\/journal.pone.0038711","volume":"7","author":"A N\u00e4sman","year":"2012","unstructured":"N\u00e4sman A, Romanitan M, Nordfors C et al (2012) Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS ONE 7(6):e38711. https:\/\/doi.org\/10.1371\/journal.pone.0038711","journal-title":"PLoS ONE"},{"issue":"2","key":"1528_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","volume":"110","author":"MJ Ward","year":"2014","unstructured":"Ward MJ, Thirdborough SM, Mellows T et al (2014) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer 110(2):489\u2013500. https:\/\/doi.org\/10.1038\/bjc.2013.639","journal-title":"Br J Cancer"},{"issue":"5","key":"1528_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/biomedicines9050486","volume":"9","author":"JP Rodrigo","year":"2021","unstructured":"Rodrigo JP, S\u00e1nchez-Canteli M, L\u00f3pez F et al (2021) Tumor-infiltrating lymphocytes in the tumor microenvironment of laryngeal squamous cell carcinoma: systematic review and meta-analysis. Biomedicines 9(5):486. https:\/\/doi.org\/10.3390\/biomedicines9050486","journal-title":"Biomedicines"},{"issue":"1","key":"1528_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3892\/or.2014.3553","volume":"33","author":"W Sun","year":"2015","unstructured":"Sun W, Li WJ, Fu QL et al (2015) Functionally distinct subsets of CD4+ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression. Oncol Rep 33(1):354\u2013362. https:\/\/doi.org\/10.3892\/or.2014.3553","journal-title":"Oncol Rep"},{"issue":"1","key":"1528_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","volume":"16","author":"A Sk\u00e1lov\u00e1","year":"2022","unstructured":"Sk\u00e1lov\u00e1 A, Hyrcza MD, Leivo I (2022) Update from the 5th edition of the World Health Organization Classification of head and neck tumors: salivary glands. Head Neck Pathol 16(1):40\u201353. https:\/\/doi.org\/10.1007\/s12105-022-01420-1","journal-title":"Head Neck Pathol"},{"issue":"6","key":"1528_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.bulcan.2018.04.004","volume":"105","author":"V Sarradin","year":"2018","unstructured":"Sarradin V, Siegfried A, Uro-Coste E, Delord JP (2018) Classification de l\u2019OMS 2017 des tumeurs de la t\u00eate et du cou\u202f: principales nouveaut\u00e9s et mise \u00e0 jour des m\u00e9thodes diagnostiques [WHO classification of head and neck tumours 2017: main novelties and update of diagnostic methods]. Bull Cancer 105(6):596\u2013602. https:\/\/doi.org\/10.1016\/j.bulcan.2018.04.004","journal-title":"Bull Cancer"},{"key":"1528_CR15","volume-title":"Malignant salivary gland tumors","author":"A Young","year":"2022","unstructured":"Young A, Okuyemi OT (2022) Malignant salivary gland tumors. StatPearls Publishing, Treasure Island"},{"issue":"3","key":"1528_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.coms.2017.03.009","volume":"29","author":"ER Carlson","year":"2017","unstructured":"Carlson ER, McCoy JM (2017) Margins for benign salivary gland neoplasms of the head and neck. Oral Maxillofac Surg Clin N Am 29(3):325\u2013340. https:\/\/doi.org\/10.1016\/j.coms.2017.03.009","journal-title":"Oral Maxillofac Surg Clin N Am"},{"issue":"11","key":"1528_CR17","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s00405-016-4000-y","volume":"273","author":"S Andreasen","year":"2016","unstructured":"Andreasen S, Bj\u00f8rndal K, Agander TK, Wessel I, Hom\u00f8e P (2016) Tumors of the sublingual gland: a national clinicopathologic study of 29 cases. Eur Arch Otorhinolaryngol 273(11):3847\u20133856. https:\/\/doi.org\/10.1007\/s00405-016-4000-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1528_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/PAP.0b013e318202645a","volume":"18","author":"RR Seethala","year":"2011","unstructured":"Seethala RR (2011) Histologic grading and prognostic biomarkers in salivary gland carcinomas. Adv Anat Pathol 18(1):29\u201345. https:\/\/doi.org\/10.1097\/PAP.0b013e318202645a","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"1528_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.otohns.2005.08.001","volume":"133","author":"RA Lima","year":"2005","unstructured":"Lima RA, Tavares MR, Dias FL et al (2005) Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133(5):702\u2013708. https:\/\/doi.org\/10.1016\/j.otohns.2005.08.001","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"1528_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrc3246","volume":"12","author":"T Blankenstein","year":"2012","unstructured":"Blankenstein T, Coulie PG, Gilboa E, Jaffee EM (2012) The determinants of tumour immunogenicity. Nat Rev Cancer 12(4):307\u2013313. https:\/\/doi.org\/10.1038\/nrc3246","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1528_CR21","doi-asserted-by":"publisher","first-page":"E1481","DOI":"10.1002\/lary.29120","volume":"131","author":"F Sato","year":"2021","unstructured":"Sato F, Ono T, Kawahara A et al (2021) Prognostic value of tumor proportion score in salivary gland carcinoma. Laryngoscope 131(5):E1481\u2013E1488. https:\/\/doi.org\/10.1002\/lary.29120","journal-title":"Laryngoscope"},{"issue":"12","key":"1528_CR22","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","volume":"26","author":"M Linxweiler","year":"2020","unstructured":"Linxweiler M, Kuo F, Katabi N et al (2020) The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype. Clin Cancer Res 26(12):2859\u20132870. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3758","journal-title":"Clin Cancer Res"},{"key":"1528_CR23","doi-asserted-by":"publisher","first-page":"104931","DOI":"10.1016\/j.oraloncology.2020.104931","volume":"111","author":"N Kesar","year":"2020","unstructured":"Kesar N, Winkelmann R, Oppermann J et al (2020) Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer. Oral Oncol 111:104931. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104931","journal-title":"Oral Oncol"},{"issue":"4","key":"1528_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/cancers12040873","volume":"12","author":"HM Witte","year":"2020","unstructured":"Witte HM, Gebauer N, Lapp\u00f6hn D et al (2020) Prognostic impact of PD-L1 expression in malignant salivary gland tumors as assessed by established scoring criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate. Cancers (Basel) 12(4):873. https:\/\/doi.org\/10.3390\/cancers12040873","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1528_CR25","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.7150\/thno.42986","volume":"10","author":"M Alame","year":"2020","unstructured":"Alame M, Cornillot E, Cacheux V et al (2020) The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities. Theranostics 10(10):4383\u20134394. https:\/\/doi.org\/10.7150\/thno.42986","journal-title":"Theranostics"},{"issue":"4","key":"1528_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12105-020-01163-x","volume":"14","author":"K Chatzopoulos","year":"2020","unstructured":"Chatzopoulos K, Collins AR, Sotiriou S et al (2020) Increased ERBB2 gene copy numbers reveal a subset of salivary duct carcinomas with high densities of tumor infiltrating lymphocytes and PD-L1 expression. Head Neck Pathol 14(4):951\u2013965. https:\/\/doi.org\/10.1007\/s12105-020-01163-x","journal-title":"Head Neck Pathol"},{"issue":"1","key":"1528_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E et al (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol 30(1):44\u201356. https:\/\/doi.org\/10.1093\/annonc\/mdy495","journal-title":"Ann Oncol"},{"issue":"8","key":"1528_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/2326-6066.CIR-16-0031","volume":"4","author":"V Sridharan","year":"2016","unstructured":"Sridharan V, Gjini E, Liao X et al (2016) Immune profiling of adenoid cystic carcinoma: PD-L2 expression and associations with tumor-infiltrating lymphocytes. Cancer Immunol Res 4(8):679\u2013687. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0031","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1528_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.25011\/cim.v44i1.35218","volume":"44","author":"W Chen","year":"2021","unstructured":"Chen W, Fung AS, McIntyre JB et al (2021) Assessment of tumour infiltrating lymphocytes and Pd-l1 expression in adenoid cystic carcinoma of the salivary gland. Clin Invest Med 44(1):38\u201341. https:\/\/doi.org\/10.25011\/cim.v44i1.35218","journal-title":"Clin Invest Med"},{"key":"1528_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oraloncology.2018.11.028","volume":"88","author":"C Mosconi","year":"2019","unstructured":"Mosconi C, de Arruda JAA, de Farias ACR et al (2019) Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands. Oral Oncol 88:95\u2013101. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.11.028","journal-title":"Oral Oncol"},{"key":"1528_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2019.06.598","author":"C Mosconi","year":"2020","unstructured":"Mosconi C, Oliveira GAQ, de Farias ACR et al (2020) Association of the tumor-infiltrating lymphocytes with recurrence in adenoid cystic carcinoma of salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. https:\/\/doi.org\/10.1016\/j.oooo.2019.06.598","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1528_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.oraloncology.2019.01.015","volume":"90","author":"T Nakano","year":"2019","unstructured":"Nakano T, Takizawa K, Uezato A, Taguchi K, Toh S, Masuda M (2019) Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas. Oral Oncol 90:30\u201337. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.01.015","journal-title":"Oral Oncol"},{"key":"1528_CR33","volume-title":"World Health Organization classification of tumours. Pathology and genetics of head and neck tumours","year":"2005","unstructured":"Barnes L, Eveson JW, Reichart P, Sidransky D (eds) (2005) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon"},{"issue":"5","key":"1528_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cancers13050965","volume":"13","author":"S Hiss","year":"2021","unstructured":"Hiss S, Eckstein M, Segschneider P et al (2021) Tumour-infiltrating lymphocytes (TILs) and PD-L1 expression correlate with lymph node metastasis, high-grade transformation and shorter metastasis-free survival in patients with acinic cell carcinoma (AciCC) of the salivary glands. Cancers (Basel) 13(5):965. https:\/\/doi.org\/10.3390\/cancers13050965","journal-title":"Cancers (Basel)"},{"issue":"11","key":"1528_CR35","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1007\/s00405-015-3855-7","volume":"273","author":"V Vander Poorten","year":"2016","unstructured":"Vander Poorten V, Triantafyllou A, Thompson LD et al (2016) Salivary acinic cell carcinoma: reappraisal and update. Eur Arch Otorhinolaryngol 273(11):3511\u20133531. https:\/\/doi.org\/10.1007\/s00405-015-3855-7","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"1528_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2559.2012.04233.x","volume":"61","author":"S Schwarz","year":"2012","unstructured":"Schwarz S, Zenk J, M\u00fcller M et al (2012) The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis. Histopathology 61(3):395\u2013408. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04233.x","journal-title":"Histopathology"},{"issue":"6","key":"1528_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/01945998221083094","volume":"167","author":"JC Dublin","year":"2022","unstructured":"Dublin JC, Oliver JR, Tam MM et al (2022) Nodal metastases in pediatric and adult acinic cell carcinoma of the major salivary glands. Otolaryngol Head Neck Surg 167(6):941\u2013951. https:\/\/doi.org\/10.1177\/01945998221083094","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"1528_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12307-010-0051-6","volume":"4","author":"M Dutsch-Wicherek","year":"2010","unstructured":"Dutsch-Wicherek M, Lazar A, Tomaszewska R (2010) The involvement of RCAS1 in creating a suppressive tumor microenvironment in patients with salivary gland adenocarcinoma. Cancer Microenviron 4(1):13\u201321. https:\/\/doi.org\/10.1007\/s12307-010-0051-6","journal-title":"Cancer Microenviron"},{"issue":"4","key":"1528_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0002-9610(82)90416-0","volume":"144","author":"RH Spiro","year":"1982","unstructured":"Spiro RH, Huvos AG, Strong EW (1982) Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients. Am J Surg 144(4):423\u2013431. https:\/\/doi.org\/10.1016\/0002-9610(82)90416-0","journal-title":"Am J Surg"},{"key":"1528_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.archoralbio.2017.07.004","volume":"83","author":"C Mosconi","year":"2017","unstructured":"Mosconi C, Arantes DAC, Gon\u00e7alves AS et al (2017) Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma. Arch Oral Biol 83:55\u201362. https:\/\/doi.org\/10.1016\/j.archoralbio.2017.07.004","journal-title":"Arch Oral Biol"},{"issue":"2","key":"1528_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang N, Bevan MJ (2011) CD8(+) T cells: foot soldiers of the immune system. Immunity 35(2):161\u2013168. https:\/\/doi.org\/10.1016\/j.immuni.2011.07.010","journal-title":"Immunity"},{"issue":"1","key":"1528_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51(1):27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"issue":"5","key":"1528_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1034\/j.1601-0825.2002.02870.x","volume":"8","author":"PM Speight","year":"2002","unstructured":"Speight PM, Barrett AW (2002) Salivary gland tumours. Oral Dis 8(5):229\u2013240. https:\/\/doi.org\/10.1034\/j.1601-0825.2002.02870.x","journal-title":"Oral Dis"},{"key":"1528_CR44","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.2147\/OTT.S134589","volume":"10","author":"H Chang","year":"2017","unstructured":"Chang H, Kim JS, Choi YJ et al (2017) Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors. Onco Targets Ther 10:2983\u20132992. https:\/\/doi.org\/10.2147\/OTT.S134589","journal-title":"Onco Targets Ther"},{"issue":"9","key":"1528_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jop.12429","volume":"45","author":"J Lemound","year":"2016","unstructured":"Lemound J, Schenk M, Keller G et al (2016) Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas. J Oral Pathol Med 45(9):655\u2013663. https:\/\/doi.org\/10.1111\/jop.12429","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1528_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.imlet.2015.02.008","volume":"164","author":"MR Haghshenas","year":"2015","unstructured":"Haghshenas MR, Khademi B, Faghih Z, Ghaderi A, Erfani N (2015) Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunol Lett 164(2):109\u2013116. https:\/\/doi.org\/10.1016\/j.imlet.2015.02.008","journal-title":"Immunol Lett"},{"issue":"1","key":"1528_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cyto.a.22348","volume":"85","author":"L Cosmi","year":"2014","unstructured":"Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F (2014) T helper cells plasticity in inflammation. Cytometry A 85(1):36\u201342. https:\/\/doi.org\/10.1002\/cyto.a.22348","journal-title":"Cytometry A"},{"issue":"1","key":"1528_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/ijms19010089","volume":"19","author":"M Mojic","year":"2017","unstructured":"Mojic M, Takeda K, Hayakawa Y (2017) The dark side of IFN-\u03b3: its role in promoting cancer immunoevasion. Int J Mol Sci 19(1):89. https:\/\/doi.org\/10.3390\/ijms19010089","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1528_CR49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/odi.12496","volume":"22","author":"MR Haghshenas","year":"2016","unstructured":"Haghshenas MR, Khademi B, Ashraf MJ, Ghaderi A, Erfani N (2016) Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors. Oral Dis 22(6):566\u2013572. https:\/\/doi.org\/10.1111\/odi.12496","journal-title":"Oral Dis"},{"key":"1528_CR50","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3389\/fimmu.2019.01583","volume":"10","author":"M Schuster","year":"2019","unstructured":"Schuster M, Plaza-Sirvent C, Visekruna A, Huehn J, Schmitz I (2019) Generation of Foxp3+CD25- regulatory T-cell precursors requires c-Rel and I\u03baBNS. Front Immunol 10:1583. https:\/\/doi.org\/10.3389\/fimmu.2019.01583","journal-title":"Front Immunol"},{"issue":"4","key":"1528_CR51","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hed.26587","volume":"43","author":"G Schvartsman","year":"2021","unstructured":"Schvartsman G, Bell D, Rubin ML et al (2021) The tumor immune contexture of salivary duct carcinoma. Head Neck 43(4):1213\u20131219. https:\/\/doi.org\/10.1002\/hed.26587","journal-title":"Head Neck"},{"issue":"5","key":"1528_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9(5):503\u2013510. https:\/\/doi.org\/10.1038\/ni1582","journal-title":"Nat Immunol"},{"issue":"2\u20133","key":"1528_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF00192437","volume":"429","author":"HB Hellquist","year":"1996","unstructured":"Hellquist HB, Karlsson MG, Viale G et al (1996) Bcl-2 immunoreactivity in salivary gland neoplasms is unrelated to the expression of mRNA for natural killer cell stimulatory cytokines interleukin (IL)-2 and IL-12. Virchows Arch 429(2\u20133):149\u2013158. https:\/\/doi.org\/10.1007\/BF00192437","journal-title":"Virchows Arch"},{"issue":"1","key":"1528_CR54","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"MC Dieu-Nosjean","year":"2016","unstructured":"Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Saut\u00e8s-Fridman C (2016) Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev 271(1):260\u2013275. https:\/\/doi.org\/10.1111\/imr.12405","journal-title":"Immunol Rev"},{"issue":"21","key":"1528_CR55","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.3390\/cancers13215383","volume":"13","author":"N Gavrielatou","year":"2021","unstructured":"Gavrielatou N, Vathiotis I, Economopoulou P, Psyrri A (2021) The role of B cells in head and neck cancer. Cancers (Basel) 13(21):5383. https:\/\/doi.org\/10.3390\/cancers13215383","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1528_CR56","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson BH (2010) CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 185(9):4977\u20134982. https:\/\/doi.org\/10.4049\/jimmunol.1001323","journal-title":"J Immunol"},{"key":"1528_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","volume":"53","author":"X Zhou","year":"2016","unstructured":"Zhou X, Su YX, Lao XM, Liang YJ, Liao GQ (2016) CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol 53:27\u201335. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.11.003","journal-title":"Oral Oncol"},{"issue":"11","key":"1528_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W et al (2019) Defining \u201cT cell exhaustion.\u201d Nat Rev Immunol 19(11):665\u2013674. https:\/\/doi.org\/10.1038\/s41577-019-0221-9","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1528_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492\u2013499. https:\/\/doi.org\/10.1038\/ni.2035","journal-title":"Nat Immunol"},{"issue":"7","key":"1528_CR60","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192(7):1027\u20131034. https:\/\/doi.org\/10.1084\/jem.192.7.1027","journal-title":"J Exp Med"},{"key":"1528_CR61","doi-asserted-by":"publisher","first-page":"701181","DOI":"10.3389\/fonc.2021.701181","volume":"11","author":"Q Fang","year":"2021","unstructured":"Fang Q, Wu Y, Du W, Zhang X, Chen D (2021) Incidence and prognostic significance of PD-L1 expression in high-grade salivary gland carcinoma [published correction appears in Front Oncol. 2021 Dec 30;11:836903]. Front Oncol 11:701181. https:\/\/doi.org\/10.3389\/fonc.2021.701181","journal-title":"Front Oncol"},{"issue":"1","key":"1528_CR62","doi-asserted-by":"publisher","first-page":"12724","DOI":"10.1038\/s41598-019-49215-9","volume":"9","author":"D Vital","year":"2019","unstructured":"Vital D, Ikenberg K, Moch H, R\u00f6ssle M, Huber GF (2019) The expression of PD-L1 in salivary gland carcinomas. Sci Rep 9(1):12724. https:\/\/doi.org\/10.1038\/s41598-019-49215-9","journal-title":"Sci Rep"},{"issue":"1","key":"1528_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jso.24266","volume":"114","author":"T Mukaigawa","year":"2016","unstructured":"Mukaigawa T, Hayashi R, Hashimoto K, Ugumori T, Hato N, Fujii S (2016) Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas. J Surg Oncol 114(1):36\u201343. https:\/\/doi.org\/10.1002\/jso.24266","journal-title":"J Surg Oncol"},{"issue":"2","key":"1528_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines9020097","volume":"9","author":"M Kuchar","year":"2021","unstructured":"Kuchar M, Strizova Z, Capkova L et al (2021) The periphery of salivary gland carcinoma tumors reveals a PD-L1\/PD-1 biomarker niche for the evaluation of disease severity and tumor-immune system interplay. Biomedicines 9(2):97. https:\/\/doi.org\/10.3390\/biomedicines9020097","journal-title":"Biomedicines"},{"issue":"3","key":"1528_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/hed.26529","volume":"43","author":"E Guazzo","year":"2021","unstructured":"Guazzo E, Cooper C, Wilkinson L et al (2021) Therapeutic implications of immune-profiling and EGFR expression in salivary gland carcinoma. Head Neck 43(3):768\u2013777. https:\/\/doi.org\/10.1002\/hed.26529","journal-title":"Head Neck"},{"issue":"7","key":"1528_CR66","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00262-020-02551-6","volume":"69","author":"C Arolt","year":"2020","unstructured":"Arolt C, Meyer M, Ruesseler V et al (2020) Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas. Cancer Immunol Immunother 69(7):1363\u20131373. https:\/\/doi.org\/10.1007\/s00262-020-02551-6","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1528_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nri3790","volume":"15","author":"LT Nguyen","year":"2015","unstructured":"Nguyen LT, Ohashi PS (2015) Clinical blockade of PD1 and LAG3\u2013potential mechanisms of action. Nat Rev Immunol 15(1):45\u201356. https:\/\/doi.org\/10.1038\/nri3790","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"1528_CR68","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.4049\/jimmunol.0903879","volume":"184","author":"C Camisaschi","year":"2010","unstructured":"Camisaschi C, Casati C, Rini F et al (2010) LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. J Immunol 184(11):6545\u20136551. https:\/\/doi.org\/10.4049\/jimmunol.0903879","journal-title":"J Immunol"},{"key":"1528_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejca.2022.05.007","volume":"171","author":"C Even","year":"2022","unstructured":"Even C, Delord JP, Price KA et al (2022) Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Eur J Cancer 171:259\u2013268. https:\/\/doi.org\/10.1016\/j.ejca.2022.05.007","journal-title":"Eur J Cancer"},{"issue":"1","key":"1528_CR70","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijrobp.2020.08.018","volume":"109","author":"U Mahmood","year":"2021","unstructured":"Mahmood U, Bang A, Chen YH et al (2021) A randomized phase 2 study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma. Int J Radiat Oncol Biol Phys 109(1):134\u2013144. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1528_CR71","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","volume":"26","author":"CP Rodriguez","year":"2020","unstructured":"Rodriguez CP, Wu QV, Voutsinas J et al (2020) A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer. Clin Cancer Res 26(4):837\u2013845. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2214","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1528_CR72","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/annonc\/mdx399","volume":"28","author":"JS Ross","year":"2017","unstructured":"Ross JS, Gay LM, Wang K et al (2017) Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies. Ann Oncol 28(10):2539\u20132546. https:\/\/doi.org\/10.1093\/annonc\/mdx399","journal-title":"Ann Oncol"},{"key":"1528_CR73","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1200\/JCO.2019.37.15_suppl.6083","volume":"37","author":"J Fayette","year":"2019","unstructured":"Fayette J, Even C, Digue L et al (2019) NISCAHN: a phase II, multi-center nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent\/metastatic (R\/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group. J Clin Oncol 37:6083. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.6083","journal-title":"J Clin Oncol"},{"issue":"6","key":"1528_CR74","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D (2022) Clinical relevance of tumour-associated macrophages [published correction appears in Nat Rev Clin Oncol. 2022 Apr 6]. Nat Rev Clin Oncol 19(6):402\u2013421. https:\/\/doi.org\/10.1038\/s41571-022-00620-6","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"1528_CR75","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"1528_CR76","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555. https:\/\/doi.org\/10.1016\/s1471-4906(02)02302-5","journal-title":"Trends Immunol"},{"issue":"1","key":"1528_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"issue":"3","key":"1528_CR78","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196(3):254\u2013265. https:\/\/doi.org\/10.1002\/path.1027","journal-title":"J Pathol"},{"issue":"11","key":"1528_CR79","doi-asserted-by":"publisher","first-page":"e20191847","DOI":"10.1084\/jem.20191847","volume":"217","author":"M Donadon","year":"2020","unstructured":"Donadon M, Torzilli G, Cortese N et al (2020) Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis. J Exp Med 217(11):e20191847. https:\/\/doi.org\/10.1084\/jem.20191847","journal-title":"J Exp Med"},{"issue":"11","key":"1528_CR80","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","volume":"8","author":"MH Barros","year":"2013","unstructured":"Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G (2013) Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE 8(11):e80908. https:\/\/doi.org\/10.1371\/journal.pone.0080908","journal-title":"PLoS ONE"},{"issue":"3","key":"1528_CR81","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1245\/s10434-008-0259-6","volume":"16","author":"YS Shieh","year":"2009","unstructured":"Shieh YS, Hung YJ, Hsieh CB, Chen JS, Chou KC, Liu SY (2009) Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands. Ann Surg Oncol 16(3):751\u2013760. https:\/\/doi.org\/10.1245\/s10434-008-0259-6","journal-title":"Ann Surg Oncol"},{"key":"1528_CR82","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fonc.2019.00231","volume":"9","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li H, Wang W et al (2019) CCL2\/CCR2 Axis promotes the progression of salivary adenoid cystic carcinoma via recruiting and reprogramming the tumor-associated macrophages. Front Oncol 9:231. https:\/\/doi.org\/10.3389\/fonc.2019.00231","journal-title":"Front Oncol"},{"issue":"20","key":"1528_CR83","doi-asserted-by":"publisher","first-page":"e15402","DOI":"10.1097\/MD.0000000000015402","volume":"98","author":"C Li","year":"2019","unstructured":"Li C, Chen Q, Tian Z et al (2019) Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value. Medicine (Baltimore) 98(20):e15402. https:\/\/doi.org\/10.1097\/MD.0000000000015402","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1528_CR84","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00432-012-1330-z","volume":"139","author":"H Liu","year":"2013","unstructured":"Liu H, Chen G, Zhang W et al (2013) Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol 139(2):287\u2013295. https:\/\/doi.org\/10.1007\/s00432-012-1330-z","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-023-01528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-023-01528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-023-01528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T06:30:32Z","timestamp":1687761032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-023-01528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":84,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1007\/s12105-023-01528-y","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"For this type of study informed consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}